RXRA and diabetic kidney disease: Tested transcripts did not correlate with gender, age, diabetic nephropathy, types of dyslipidemia, active HBV/HCV infection, liver enzyme activities but ALP with RXRA transcript, inflammatory state assessed by plasma C-reactive protein, or lipid-modifying treatment (Additional file 1: Table S11).